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Improving our understanding of the mechanisms controlling the corpus luteum (CL) and its role in regulating the reproductive cycle should lead to improvements in the sustainability of today's global animal industry. The corpus luteum (CL) is a transient endocrine organ composed of a heterogeneous mixture steroidogenic, endothelial and immune cells, and it is becoming clear that immune mechanisms play a key role in CL regulation especially in luteolysis. Toll-like receptors (TLR) mediate innate immune mechanisms via the production of pro-inflammatory cytokines, especially within various tissues, although the role of TLR within CL remains unknown. Thus, the objectives of this study were to characterize TLR mRNA expression in the CL during the oestrous cycle and in pregnancy (day 30-50), and to examine the role of TLR signalling in luteal cells. Corpora lutea were collected at various stages of the cycle and pregnancy and analysed for TLR and cytokine mRNA expression. In addition, luteal cells were cultured with the TLR4 ligand (lipopolysaccharide, LPS) for 24 h to evaluate the role of TLR4 in regulating luteal function. Toll-like receptors 1, 2, 4, 6, tumour necrosis factor alpha (TNF), interferon gamma (IFN-G), and interleukin (IL)-12, mRNA expressions were greatest in regressing CL compared with earlier stages (p < .05), whereas no change was observed for IL-6 mRNA expression. Cytokine mRNA expression in cultured luteal cells was not altered by LPS. Based on these data, one or more of the TLRs found within the CL may play a role in luteolysis, perhaps via pro-inflammatory cytokine mRNA expression.
| INTRODUCTION
Understanding the complex molecular regulatory mechanisms involved in the maintenance or regression (luteolysis) of the bovine corpus luteum (CL) is essential to the development of improved methods for enhancing reproductive efficiency of dairy cattle, especially as continued secretion progesterone by the CL is critical for embryonic survival and the successful outcome of pregnancy. Luteolysis has been described as a pro-inflammatory event (Walusimbi & Pate, 2013) , and there is strong evidence to show that the pro-inflammatory cytokines (e.g. tumour necrosis factor (TNF), interferon gamma (IFN-G) and interleukin 1 beta (IL-1B) display elevated levels of mRNA expression in bovine CL undergoing natural or prostaglandin (PG) F-2α-induced luteolysis (Neuvians, Schams, Berisha, & Pfaffl, 2004; Petroff, Petroff, & Pate, 2001) . Furthermore, TNF and IFN-G treatment of bovine luteal cells in vitro inhibited progesterone production in a dose-dependent manner, indicating that these cytokines have luteolytic actions (Petroff et al., 2001 ; Skarzynski, Ferreira-Dias, & Okuda, 2008; Walusimbi & Pate, 2013) . Lastly, TNF and IFN-G have been shown to act synergistically to promote luteal cell death (Petroff et al., 2001; Walusimbi & Pate, 2013) . One ligand/receptor system that regulates inflammation in tissues is the toll-like receptors (TLR) and their ligands. In view of their involvement in promoting inflammation and our need to investigate further the control of inflammation during luteolysis in the bovine CL, we chose to examine the mRNA expression of these receptors in bovine CL throughout the oestrous cycle and during pregnancy.
Toll-like receptors are critical components of the innate immune system, allowing host cells to recognize and mount an appropriate response (e.g. inflammation) to microbial pathogens that the host organism may encounter (Aflatoonian & Fazeli, 2008; Kawai & Akira, 2010) . Toll-like receptors are members of the pattern recognition receptor (PRR) family that have evolved to recognize protein domains/ sequences on various pathogens, which are known as pathogenassociated molecular patterns (PAMPs) (Aflatoonian & Fazeli, 2008; Kawai & Akira, 2010) . There are currently 10 (human, bovine) or 12 (mouse) different TLR, each of which has a relatively well-defined function (Aflatoonian & Fazeli, 2008; Davies et al., 2008; Kawai & Akira, 2010) . Toll-like receptors 1, 2, 4 and 6 are associated with the plasma membrane and enable recognition of a variety of PAMPS produced by bacteria, viruses, fungi or parasites. Additionally, lipopolysaccharide (LPS) and triacyl lipopeptides produced by Gram-negative bacteria such as E. coli are recognized by TLR4, and by TLR1 and TLR2 heterodimers, respectively, and diacyl lipopeptides of Gram-positive bacteria are recognized by TLR2 and TLR6 heterodimers (Aflatoonian & Fazeli, 2008; Kawai & Akira, 2010) . On the other hand, TLR3, 7 and 8 are intracellular receptors and recognize internalized bacterial or viral nucleic acids (Aflatoonian & Fazeli, 2008; Kawai & Akira, 2010) . Little is known about the function of, or ligand for, TLR 10, but it is homologous to TLR2 and is likely a TLR2-associated receptor (Aflatoonian & Fazeli, 2008) . However, TLR (e.g. TLR2 and 4) activation has also been shown to occur in response to the products of normal cellular degradation, such as heat-shock proteins (HSP) and high-mobility group box 1 (HMGB1) proteins, and thus, TLR-mediated pro-inflammatory cytokine production may occur quite independently of microbial infection (Kawai & Akira, 2010) . Furthermore, as luteolysis involves widespread cellular degeneration, it is likely that the regressing CL during the oestrous cycle would represent a rich source of potential endogenous ligands to activate TLRs expressed within this tissue in otherwise healthy animals.
The responses of toll-like receptors to microbial pathogens have been studied in reproductive tissues such as the bovine uterus (endometrium) and ovary (Battaglia, Krasa, Padmanabhan, Viguie, & Karsch, 2000; Davies et al., 2008; Herath et al., 2007; Sheldon, Noakes, Rycroft, Pfeiffer, & Dobson, 2002; Sheldon et al., 2009) . These investigators demonstrated several TLRs in the endometrium and examined their role in response to pathogens in cattle with uterine infections (e.g. endometritis, metritis or pyometra). Lipopolysaccharide (LPS), produced by E. coli, a common causative agent of uterine infections in dairy cows, binds to TLR4 on uterine epithelial cells. This induces a pro-inflammatory cascade of cytokines leading to altered prostaglandin (PG) production (increased PGE-2:PGF2α ratio) by the uterus (Davies et al., 2008; Sheldon et al., 2009 ) which causes delayed luteolysis and extended cycles in animals with uterine infections (Davies et al., 2008; Saut, Healey, Borges, & Sheldon, 2014; Sheldon et al., 2009) . In other studies, it was shown that LPS concentrations in peripheral blood (Mateus, Lopes da Costa, Diniz, & Ziecik, 2003) , and within the ovarian follicular fluid , are elevated in animals with uterine infections, suggesting that LPS may also have direct effects on ovarian function. Indeed, oestrogen production and follicular growth are reduced in animals with uterine infections or in response to LPS infusion (Battaglia et al., 2000; Herath et al., 2007; Sheldon et al., 2002) . It is also known that smaller follicles produce smaller CL with lower serum progesterone concentrations (Perry et al., 2005; Robinson, Hammond, Hunter, & Mann, 2005) , which may help to explain lower than normal luteal phase progesterone concentrations observed in animals with uterine infections (Sheldon et al., 2009 ). Furthermore, LPS has been shown to exert direct actions on the CL as shown by studies in which bovine luteal cells were cultured with increasing doses of LPS, resulting in increased progesterone secretion (Grant, Lilly, Herath, & Sheldon, 2007) . Taken together, these data suggest that in cows with uterine infections, microbial pathogens such as LPS may also exert direct effects on the CL.
In view of the importance of improving our understanding about the role of cytokines and their role in the inflammatory luteolytic process, the overall goal of this study was to examine the potential roles that TLR may have within the CL during the bovine oestrous cycle versus pregnancy, with particular emphasis on their possible roles, via pro-inflammatory actions, in the control of luteolysis. This study was designed to carry out the following Primary Objectives:
1. To determine the steady-state levels of mRNA expression of multiple TLR and cytokines in the bovine CL collected at different stages of the oestrous cycle and pregnancy, and 2. To examine the effects of LPS on cytokine mRNA expression by bovine luteal cells in culture.
| MATERIALS AND METHODS

| Tissue collection
Ovaries were collected from a local abattoir (Martin's Abattoir and Wholesale Meats, Godwin, NC). Approval to obtain specimens from this official establishment was granted by the North Carolina Department of Agriculture and Consumer Services Meat and Poultry Inspection Division. Corpora lutea (CL; n = 51) were collected and catalogued by stage (I, II, III, IV, or Pregnant [P]) based on appearance, ovarian and reproductive tract morphology (Ireland, Murphee, & Coulson, 1980) . Corpora lutea collected at stage I (~days 1-4: n = 7), stage II (~days 5-10: n = 11), stage III (~days 11-17: n = 11), stage IV (~days 18-20: n = 13) and from pregnancy (~ 30-50 days: n = 7) were used for these experiments. Corpora lutea of pregnancy were confirmed by the presence of embryos in the uterus. Stage of pregnancy was estimated by conceptus size or crown-rump length measurement (by Dr. Peter Farin). Following collection, luteal tissues were frozen at −80°C until analysis for mRNA or progesterone concentrations.
Additional mid-stage (stage II; n = 6) CL were collected and placed into ice-cold Hams F-12 media (Gibco, Invitrogen Corporation, Carlsbad, CA, USA) during transport to the laboratory to be dissociated for culture experiments.
| Dissociation of corpora lutea
Corpora lutea were collected, and dissociation of luteal tissue was performed according to Pate (1993) (Pate, 1993; Poole & Pate, 2012) . Enrichment of small and large luteal cells as previously described (Pate, 1993; Poole & Pate, 2012) was confirmed in this set of experiments. Following dissociation, luteal cells were re-suspended in Ham's F-12 culture medium and cell viability was determined via standard viability stain (trypan blue; Sigma-Aldrich). Cells were placed in a 0.5% trypan blue solution, and counted on a hemacytometer according to Pate (1993) with cell viability routinely ≥80% live cells.
| Luteal cell culture
Luteal cells (1.0 × 10 6 cells/ml) were plated to approximately 75% confluency in 24-well plates in 24 mM HEPES-buffered Ham's F-12 culture medium (Gibco, Invitrogen) containing 5% FCS (Sigma-Aldrich), 20 μg/ml gentamicin (Gentamicin Reagent Solution; Invitrogen) and incubated for 24 h at 37°C and 5% CO 2 in air. After 24 hr, media were replaced to remove dead cells and debris. Luteal cells were treated with LPS (TLR4 ligand; cat # L3024; Sigma-Aldrich) at 0, 0.01, 0.1, 1 μg/ml concentrations and were incubated at 37°C and 5% CO 2 in air, for additional 24 hr. These LPS doses have been shown to be effective in increasing progesterone secretion by bovine luteal cells in culture (Grant et al., 2007) . After culture, media were removed and luteal cells were harvested to quantify cytokine mRNA by quantitative PCR (qPCR). Culture experiments were repeated a total of three times using CL from different animals.
| Total RNA extraction and PCR
| RNA Extraction and semi-quantitative PCRbovine CL whole-tissue samples
RNA was extracted from luteal tissue (approximately 100 mg) using 1 ml of TRIzol (Sigma-Aldrich) and homogenization as described by Crosier et al. (2002) . Following RNA isolation, RNA pellets were allowed to dry at room temperature for 5 min and were then dissolved in nuclease-free diH 2 O (Sigma-Aldrich) in volumes ranging from 10 to 60 μl based on pellet size. The concentration of RNA and the 260 nm: 280 nm OD ratio were determined by Nanodrop 2000
Spectrophotometer (Thermo Scientific, Waltham, MA, USA). RNA samples were then subjected to DNase treatment followed by cDNA synthesis and semi-quantitative PCR as described previously (Crosier et al., 2002) . For optimum synthesis efficiency, 1 μg of RNA was reversed transcribed in a total volume of 20 μl per reaction in accordance with manufacturers' recommendations. RNA was determined to be of high quality based on a 260:280 ratio of 1.8 or more, and this was confirmed by the presence of clear 28S and 18S rRNA bands on denaturing agarose gels stained with ethidium bromide. Primers for this procedure were synthesized based upon the published GenBank sequences to produce the expected product sizes (see Table 1 ). All 
| RNA Extraction and quantitative (Q)-PCRbovine CL whole-tissue and cell culture samples
Total RNA was extracted and purified from luteal tissues at various stages of the oestrous cycle/pregnancy and the cultured luteal cells, 
| Progesterone radioimmunoassay
The method for the extraction and assay of CL progesterone concentrations was adapted from previously published methods (Estill, Britt, & Gadsby, 1995; Garverick et al., 1985) . Briefly, approximately 100 mg of luteal tissue was immersed in 10 ml of cold 100% ethanol and homogenized. After centrifugation, the ethanol extract was dried under nitrogen and re-constituted in radioimmunoassay buffer (phosphate-buffered saline plus 0.1% gelatin; PBS-gel; Estill et al., 1995) . CL samples and progesterone standards (25-2000 pg/ml) were assayed in duplicate using the Coat-a-count RIA kit (Coat-a-count, Diagnostic Products Corporation, Los Angeles, CA, USA) following the manufacturers' instructions (Estill et al., 1995; Richards, Gadsby, & Almond, 1994) . All samples were run in a single assay, and the intraassay coefficient of variation was 6.3%. The sensitivity of this assay was 10 pg progesterone per tube (Richards et al., 1994) . This assay has also been validated in our laboratory for use with bovine serum in a single assay (Lyons, Shaeffer, Drewnoski, Poore, & Poole, 2016; Whisnant & Burns, 2002) . Data are reported as nanograms of progesterone/mg luteal tissue.
| Statistical analysis
All statistical analyses were performed using the mixed model of SAS (Statistical Analysis System Institute, Cary, NC, USA). mRNA expression data were log-transformed and analysed using covariate analysis, with RPL19 as the covariate for Q-PCR and ACTB as the covariate for semi-quantitative PCR. One-way ANOVA was performed to determine differences among stages of luteal development for progesterone concentrations. In addition, a correlation analysis (PROC CORR) was conducted to determine the relationship between the mRNA expression of TLR and pro-inflammatory cytokines within bovine luteal tissue. Cell culture experiments were independently replicated with cells from different animals a minimum of three times unless otherwise stated. Additionally, the cell culture experiment was analysed for linear, quadratic and cubic relationships using a PROC GLM with orthogonal contrast for respective relationships. Differences were considered significant at p < .05, and a statistical tendency was declared when .05 < p < .1.
| RESULTS
| Progesterone concentrations within bovine CL
Whole-tissue CL progesterone concentrations were significantly decreased to 6.5 ± 2.2 ng/mg in stage IV CL, from ~ 30 to 40 ng/mg observed in CL from stages I, II, III, and in pregnancy (p < .001). These CL progesterone concentrations are in agreement with those published by Garverick and colleagues (Garverick et al., 1985) in the bovine CL, who used a similar CL extraction procedure for progesterone.
| TLR 1, 2, 4 and 6 mRNA expression
The steady-state mRNA expression levels of toll-like receptors 1, 2, 4 and 6 mRNAs were examined in whole-tissue CL samples via Q-PCR (Figure 1 ). Toll-like receptor 1 mRNA expression was significantly increased in stage IV compared to stages I, II and III (p < .01). Similar stage-dependent profiles were seen for TLR2, TLR4 and TLR6 with a significant increase at stage IV compared to stages I, II, III and pregnancy (p < .01; p < .05; p < .05; respectively). There was also a tendency for pregnancy to show increased TLR6 mRNA expression over stage II (p < .1). T A B L E 2 Primer Sequences for quantitative real-time PCR F I G U R E 1 Toll-like receptor (TLR)1, 2, 4 and 6 mRNA expression, via quantitative real-time PCR, at various stages of luteal development (I = days 1-4: n = 7, II = days 5-10: n = 11, III = days 11-17: n = 11, IV = days 18-20 of the oestrous cycle: n = 13, and P = pregnancy: n = 9). Expression of TLR1, 2, 4 and 6 increased in the regressing CL (days 18-20 of the oestrous cycle) compared to other stages of the oestrous cycle. Data are presented as least-squared means ± SEM. Different letters within a specific gene indicate significant differences (p < .05)
| TLR3, 7, 8 and 10 mRNA expression
Analysis of steady-state mRNA levels of TLR3, 7, 8 and 10 was carried out by semi-quantitative (sQ) PCR, and the data are summarized in Table 3 . No significant differences were observed between the stages of the cycle or pregnancy for any of these TLRs. TLR3 mRNA expression at stage IV tended to be lower (p < .1) than stage III. TLR8 mRNA expression tended to be lower in pregnancy compared to stage IV (p < .1).
| MD2, CD14 and CD45 mRNA expression
An examination of the expression levels of MD2, CD14 and CD45 mRNAs was also carried out by semi-quantitative (sQ) PCR (Table 3) .
Lymphocyte antigen (MD2) and CD14 were examined as they repre- 
| Cytokine mRNA expression
Interferon gamma, IL6, IL12 and TNF mRNA expression was also examined in whole-tissue CL samples by Q-PCR (Figure 2 ). IFN-G was significantly increased at stage IV compared to stages I, II, III and pregnancy (p < .05). Interleukin-12 mRNA expression displayed a similar profile with a significant increase observed at stage IV vs. (Table 4 and Figure 3 ). No significant correlations were found between TLR1, 2, 4, and 6 and IL-6 (Table 4 ).
| Cytokine mRNA expression in bovine luteal cells treated with LPS in culture
Luteal cells were dissociated and cultured for 24 h with LPS (0, 0.01, Additional analyses to test for a linear, quadratic or cubic relationships Data are represented as least-squared means ± SEM and different letters within a row indicate significant differences (p < .05), whereas * within a row indicates statistical tendencies (.1 < p > .05)
0.1, 1 μg/ml). Cytokine (TNF, TGF-β, IFN-G, IL-6 and
T A B L E 3 mRNA expression, via semi-quantitative PCR, of various toll-like receptors (TLR3, 7, 8, and 10) and their co-activators, Lymphocyte antigen (MD2) and cluster of differentiation (CD) 14, and 45, at various stages of luteal development (I = days 1-4: n = 7, II = days 5-10: n = 11, III = days 11-17: n = 11, IV = days 18-20 of the oestrous cycle: n = 13, and P = pregnancy: n = 9)
transforming growth factor beta (TGFB) and tumour necrosis factor alpha (TNF) mRNA expression, via quantitative real-time PCR, at various stages of luteal development (I = days 1-4: n = 7, II = days 5-10: n = 11, III = days 11-17: n = 11, IV = days 18-20 of the oestrous cycle: n = 13, and P = pregnancy: n = 9). Expression of TNF, IFN-G, and IL-12 increased in the regressing CL (days 18-20 of the oestrous cycle) compared to other stages of the oestrous cycle. Data are presented as least-squared means ± SEM. Different letters within a specific gene indicates significant differences (p < .05), whereas * within a specific gene indicates statistical tendencies (.1 < p > .05)
for cytokine mRNA expression relative to LPS doses were carried out, but did not show any significance (p > .05).
| DISCUSSION
The major focus of this study was to improve our understanding of role of TLR in the pro-inflammatory/luteolytic process during the oestrous cycle in normal animals. However, the data described here may also be viewed from the perspective that in the CL of cows with uterine infections, and TLRs may also respond to the direct actions microbial agents, leading to inappropriate inflammatory pathways that may have adverse impacts on the CL, reproductive cyclicity and pregnancy in these animals.
The studies described above provide compelling evidence for the expression of mRNAs for eight different TLRs (i.e. TLR1, 2, 3, 4, 6, 7, 8 and 10) within the bovine CL by PCR analysis. TLR1-TLR10 mRNAs were also found to be expressed in bovine follicles raising the possibility that TLR mRNA expression continues following ovulation and during luteinization of the follicle into a fully functioning CL Price, Bromfield, & Sheldon, 2013) .
Stage IV CL are essentially CL undergoing luteal regression as confirmed by the reduced CL progesterone concentrations seen at this stage, which prompts us to suggest that the increase of TLR1, 2, 4 and 6 mRNA expression (Figure 1 ) may be associated with, or in some way involved in, the process of luteolysis potentially through the upregulation of pro-inflammatory cytokines (IFNG, TNF and IL12; Figure 2 ).
The correlation data (Table 4 and Figure 3 ) showing significant positive correlations between TLR1, 2, 4 and 6 mRNAs and these cytokines support the notion that these TLRs may function to promote pro-inflammatory cytokine secretion during luteolysis in the cow.
Luteolysis has been described as a pro-inflammatory event (Walusimbi & Pate, 2013) , and the significantly elevated mRNA expression of pro-inflammatory cytokines TNF, IFN-G and IL-12 mRNA observed in this study in stage IV CL support this notion. Numerous studies have demonstrated that TNF and IFN-G act as luteolytic, and (cooperatively) as cytotoxic, agents within the bovine CL (Petroff et al., 2001; Skarzynski et al., 2008; Walusimbi & Pate, 2013) , and these cytokines have been shown by others to display elevated mRNA expression in regressing bovine CL (Petroff et al., 2001) . Furthermore, Neuvians and colleagues (Neuvians et al., 2004) have shown that PGF2α treatment of cows increased TNF, IFN-G, and IL-1B mRNA expression, and that TNF and IFN-G treatment of bovine luteal cells in vitro inhibited progesterone production in a dose-dependent manner. , which was also elevated in regressing CL in our studies, is a classical pro-inflammatory cytokine, and was shown to promote natural killer cell differentiation, leading to increased IFN-G mRNA expression (Yang, Kong, Mosser, & Zhang, 2011 these TLRs in the bovine CL of a normal healthy animal, in the absence of ligands (e.g. LPS) generated by bacteria or viruses. It has been suggested that the breakdown products of luteal tissue and dead or dying cells, such as those of the extracellular matrix, heat-shock proteins and high-mobility group box 1 (HMGB1) proteins, may activate TLR (e.g.
TLR2 and 4) and thus promote pro-inflammatory cytokine production (Kawai & Akira, 2010) . As stage IV represents regressing (i.e. degenerating) CL, it is likely that this would represent a rich source of potential endogenous ligands to activate TLRs expressed within this tissue.
The results presented here for TLR 2 and 4 are consistent with a recent publication showing that these two TLR are expressed in the bovine CL, and that their mRNA expression was increased in CL collected at mid-and late stages of the oestrous cycle, compared with those collected during the early cycle (Luttgenau et al., 2016) . These investigators were also able to demonstrate the mRNA expression of TLR 2 and 4 at the protein level using immunohistochemistry, and they observed immunoreactivity in both endothelial and luteal cells, providing some critical insights into the cellular location of these TLRs (Luttgenau et al., 2016) .
Even though it is clear that TLR 2 and 4 are expressed on luteal and endothelial cells in non-regressing CL (Luttgenau et al., 2016) , it is possible that as luteolysis proceeds, at least some of the increased TLR2
and 4 mRNA's observed in the regressing (stage IV) bovine CL described above may be associated with increased immune cell (e.g. macrophages, T cells, and neutrophils) infiltration into the CL (Walusimbi & Pate, 2013) . In the present study, CD45, which is a common leucocyte marker (Aflatoonian & Fazeli, 2008; Kawai & Akira, 2010) CL is difficult to explain as this is a time when immune cell infiltration would be maximal (Walusimbi & Pate, 2013) .
Further evidence to indicate that TLR4 in bovine CL is functional comes from our data showing that two critical components of TLR4 signalling in response to its ligand LPS, namely MD2 and CD14, were also expressed at mRNA level in the bovine CL. MD2, which is a TLR4 co-receptor, is located found on the external cell membrane and aids in the binding of ligand (e.g. LPS) to the extracellular domain of the TLR4 dimer (Hirata et al. 2005) . Cluster of differentiation (CD) 14 also plays a role in the binding of LPS to TLR4, and is an essential component of the functional TLR4 complex (Kawai & Akira, 2010) . The mRNA expression of CD14 and MD2 mRNAs seen in fully functional CL (stage III) was significantly elevated compared with early (stage I) and late (IV) stages, suggesting that these components are expressed prior to the elevated mRNA expression of TLR4 seen at stage IV, to prepare the TLR4 receptor signalling complex for a critical role in luteal regression.
It should be noted that TLR2 and 4, and all cytokine mRNAs, were found to be decreased in pregnancy vs. stage IV CL. The general pattern of reduced pro-inflammatory TLR and cytokine mRNA expression profiles during gestation may be needed to prevent luteolysis, and ensure sufficient progesterone secretion to maintain pregnancy and embryo survival (Aflatoonian & Fazeli, 2008 (Maroni & Davis, 2011 ).
In the current study, the intracellular TLRs (TLR3, TLR7 and TLR8)
did not display significantly different mRNA expression profiles at different stages of the oestrous cycle or pregnancy. These TLRs recognize viral or bacterial nucleic acids (Kawai & Akira, 2010) , and given the location of the CL, the likelihood of luteal cells coming into direct contact with bacteria or viruses is probably very small. Thus, the function of these TLR within the CL is unknown and warrants further investigation. However, it has been suggested that DNA arising from dead or dying cells may bind these TLR and activate their intracellular pathways (Kawai & Akira, 2010) . Thus, as luteolysis results in wholesale death of multiple cells types, these TLR may also play an important role within the regressing CL.
In the culture studies, we used dissociated bovine luteal cells from mid-cycle (stage II) CL to examine a functional role of TLR4, using its ligand LPS, on cytokine production, as a model for the pro-inflammatory response seen during luteolysis. Yet, multiple analyses of linear, quadratic and cubic relationships between different LPS treatment doses were unable to reveal any statistically significant changes in cytokine mRNA expression, even though some numerical increases in IFN-G and IL-6 mRNA expression were evident. There are several possible explanations for the apparent lack of an effect of LPS on luteal cell cytokine mRNA expression. Firstly, while the CL used for these studies were stage II, to maximize the yield of viable luteal cells and their survival during the culture, TLR4 levels (mRNA expression) were quite low at these stages, and only increased in stage IV CL. It is possible that while a more robust response to LPS may be observed in stage IV cells in vitro, obtaining sufficient viable and culture-healthy cells to carry out this study would probably represent an insurmountable challenge.
Secondly, the CL is a heterogeneous tissue composed of multiple cell types such as large luteal cells, small luteal cells, fibroblasts, endothelial cells and immune cells (Skarzynski et al., 2008) , many of which may express TLR4 and be targets for LPS (Aflatoonian & Fazeli, 2008; Kawai & Akira, 2010; Luttgenau et al., 2016) . Variations in the viability or proportion of any of these cell types could contribute to the variability seen in these cultures, which did show some evidence of a numerical increase in IFN-G and IL-6 at the highest dose, but were not significant.
It is worth noting that in recent studies, the effects of LPS on bovine (mid-cycle) CL function were examined in vivo, and decreased enzymes associated with progesterone secretion and elevated IL-1B and TNF mRNA expressions were observed (Luttgenau et al., 2016) , suggesting that the bovine luteal TLR4 receptor acts as a functional receptor.
In conclusion, we have presented evidence for the mRNA expression of several TLR, TLR4 accessory proteins (CD14 and MD2) and cytokine mRNAs in bovine CL, which appear to be maximal in mid-(stage III; CD14 and MD2) and late (stage IV; TLR and cytokines) CL. These findings suggest an involvement of one or more of the TLR in the process of luteolysis, and perhaps in the increased mRNA expression of proinflammatory cytokines, which also play a role in luteolysis. Finally, in view of the prevalence of infectious diseases such as uterine infections (Sheldon et al., 2009 ) and mastitis (Barker, Schrick, Lewis, Dowlen, & Oliver,1998) in dairy cattle, the data presented in this manuscript also raise the possibility that TLR on the bovine CL may mediate adverse effects of infectious pathogens, leading to infertility or subfertility.
